Integrated smart technology builds on TempraMed's proven VIVI platform, providing robust Temperature control with medication management for individuals using life-saving medicationHighlights: Expands ...

Managing diabetes is set to change dramatically by 2026. Endocrinologist reveals 5 cutting-edge technologies that will make ...

California health care faced major cuts in 2025 as federal Medicaid funding dropped and ACA subsidies stalled, threatening millions.

Researchers warn that spending most of our time indoors could be an overlooked risk factor for metabolic diseases ...

Jonty Brown became one of the first people to get an "artificial pancreas" from the NHS - and is now an ultramarathon runner.

Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) ...

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

GLP-1 medicines have been utilised for the treatment of diabetes; however, they are now emerging as important topics for the treatment of obesity ...

TempraMed Technologies Ltd. ( ($TSE:VIVI) ) has shared an update. TempraMed Technologies Ltd., a med‑tech firm focused on temperature-controlled ...

The "Liraglutide and Semaglutide - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Liraglutide and Semaglutide was valued at US$17.1 ...

Alisha Trafford was thrilled when Mounjaro helped her to lose weight-but after discovering the medication had 'destroyed' one ...

A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic Nineties and beach-body-ready Noughties, the judgement is real. It is ...